Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-044445

Pres and CEO gave up 4,437 shares (to pay taxes)

  • Pres and CEO acquired 15,575 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Manion Douglas J. · Pres and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-01 Exercise or conversion : show line 1 in the form +15,575 28,375 D
2023-08-01 Shares withheld for taxes : show line 2 in the form −4,437 $9.81 $43,527 23,938 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −15,575 46,725 D
Loading xslF345X05/doc4.xml…